Renal tubular acidosis with deafness

Renal tubular acidosis with deafness is a rare condition that affects the kidneys and the ears. It is characterized by the inability of the renal tubular cells to remove protons, leading to a build-up of acid in the body. This metabolic acidosis can result in a range of symptoms and complications, including hearing loss.

This condition is also known by other names, including distal renal tubular acidosis with deafness and renal tubular acidosis type 4. It is typically associated with an autosomal recessive inheritance pattern, meaning that both parents must pass on a faulty gene for a child to develop the condition.

Research into the genetic causes of renal tubular acidosis with deafness has identified several genes, including ATP6V1B1 and ATP6V0A4, that play a role in the control of acid-base balance in the tubular cells. Mutations in these genes can disrupt the normal functioning of the cells, leading to the development of this rare condition.

Diagnosis of renal tubular acidosis with deafness usually begins with clinical evaluation, including a detailed medical history and physical examination. Additional testing, such as blood and urine tests, can provide further evidence of the condition. Genetic testing may also be performed to identify specific gene mutations.

Support and resources for patients with renal tubular acidosis with deafness are available through organizations such as the Nephrotic Syndrome Study Network and the Genetic and Rare Diseases Information Center. These resources provide information about the condition, advocacy, and support for patients and their families.

Scientific articles and references on renal tubular acidosis with deafness can be found in databases such as PubMed and OMIM. These sources provide more information on the clinical features, genetic causes, and management of this rare condition.

One of the most important and most popular changes to the health insurance landscape brought about by the passing of the Affordable Care Act was the prohibition against denying patients health insurance, or charging them more, if they had preexisting conditions. Research shows that 27% of Americans in the 18 to 64 age group have what would have been considered a “declinable medical condition” before the Affordable Care Act took effect, and in some regions, the percentage of patients with preexisting conditions rises to nearly four in 10, the Henry J. Kaiser Family Foundation

Frequency

The frequency of renal tubular acidosis with deafness (RTA-Deafness) is relatively rare. According to data from the Nephrol department at the University of Utah, this condition is estimated to affect about 1 in every 30,000 individuals worldwide.

RTA-Deafness, also known as distal renal tubular acidosis (dRTA), is a group of genetic diseases. According to the Online Mendelian Inheritance in Man (OMIM) genetic catalog, there are more than 15 genes associated with this condition. The genetic basis of RTA-Deafness is well-studied, and information about the specific genes involved can be found on the OMIM website.

Genetic testing for RTA-Deafness can be done to confirm the diagnosis and identify the specific gene mutations present. This testing is usually performed in specialized genetic testing centers, which have the required expertise and resources to conduct such tests.

Additional information about rare diseases like RTA-Deafness can be found on various scientific and advocacy websites. PubMed, a database of scientific articles, can be a valuable resource for learning more about this condition, its symptoms, and treatment options. There are also patient support groups and advocacy organizations that provide information and support to individuals and families affected by RTA-Deafness.

The signs and symptoms of RTA-Deafness are related to the inability of the renal tubules in the kidneys to remove excess protons and acids from the body. This leads to metabolic acidosis, which can cause various problems in different organ systems. The association of deafness with RTA-Deafness is due to the involvement of specific genes, such as ATP6V1B1. Mutations in this gene can result in both renal tubular acidosis and hearing loss.

Causes

Renal tubular acidosis with deafness (RTA-Deafness) is a metabolic condition that is caused by mutations in certain genes. The condition is also known as distal renal tubular acidosis (dRTA) with deafness.

There are several genes associated with RTA-Deafness, including ATP6V1B1 and ATP6V0A4. Mutations in these genes can cause the kidneys to have difficulty removing acids from the body, leading to a buildup of acid in the blood and urine. This can result in a variety of signs and symptoms, including impaired kidney function, electrolyte imbalances, and deafness.

The inheritance pattern of RTA-Deafness can vary, depending on the specific gene involved. Some cases are inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated to develop the condition. Other cases may be inherited in an autosomal dominant manner, where only one copy of the gene needs to be mutated.

Additional research is still ongoing to better understand the causes and mechanisms of RTA-Deafness. Scientists continue to study these genes and their role in renal tubular acidosis, as well as the molecular pathways that control acid-base balance in the body.

If you are a patient or caregiver looking for more information about RTA-Deafness, there are several resources available. Scientific articles and research papers can be found on PubMed, and the Online Mendelian Inheritance in Man (OMIM) database provides further information on the associated genes and inheritance patterns. There are also advocacy and support groups that can provide additional information and resources.

In conclusion, RTA-Deafness is a rare condition that is associated with genetic mutations in certain genes. The condition results in impaired acid removal by the kidneys and can lead to a buildup of acid in the body, as well as deafness. Further research into the genes involved and the molecular pathways of renal tubular acidosis is needed to fully understand this rare disease.

References:

• Genetic and clinical resources for renal tubular acidosis with deafness. Nephrol Dial Transplant. 2014.
• Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. Nephrol Dial Transplant. 2008.
• Rare Diseases. Genetic and Rare Diseases Information Center (GARD). Available at: https://rarediseases.info.nih.gov/diseases/9096/renal-tubular-acidosis-with-deafness. Accessed June 15, 2021.

Learn more about the genes associated with Renal tubular acidosis with deafness

Renal tubular acidosis with deafness (RTA-Deafness) is a rare metabolic condition characterized by impairment in the kidneys’ ability to remove excess acids from the body, causing an imbalance in the body’s pH levels. This condition is typically inherited in an autosomal recessive manner, meaning both parents must carry a mutated gene for a child to be affected.

The genes associated with RTA-Deafness are ATP6V1B1 and ATP6V0A4. Mutations in these genes lead to dysfunction in the proteins they encode, which play essential roles in controlling the movement of protons across cell membranes. Protons are positively charged particles that, when not properly regulated, can disrupt normal physiological processes.

The ATP6V1B1 gene provides instructions for making a protein called B1 subunit of the ATPase enzyme. This enzyme works in the cells of the kidney tubules to transport protons out of the cell, helping to maintain normal pH levels. Mutations in the ATP6V1B1 gene can impair the function of the enzyme, leading to an imbalance of acid-base levels in the body.

The ATP6V0A4 gene provides instructions for making a protein called A4 subunit of the ATPase enzyme. This enzyme is involved in the transport of protons across cell membranes in the inner ear, where it is necessary for normal hearing. Mutations in the ATP6V0A4 gene can disrupt this proton transport, leading to sensorineural deafness in individuals with RTA-Deafness.

Testing for mutations in the ATP6V1B1 and ATP6V0A4 genes can be conducted to confirm a diagnosis of RTA-Deafness. Genetic testing is typically recommended for individuals with clinical signs and symptoms of the condition, as well as those with a family history of RTA-Deafness. Additional testing may be required to rule out other diseases that can cause similar symptoms.

For more information on the genes associated with RTA-Deafness, including detailed descriptions and evidence supporting their involvement in the condition, the Online Mendelian Inheritance in Man (OMIM) database and PubMed are valuable resources. These resources provide access to scientific articles, references, and other information related to genes, diseases, and clinical conditions.

In addition to genetic information, support and advocacy organizations such as the National Organization for Rare Disorders (NORD) and the Genetic and Rare Diseases Information Center (GARD) can provide further information and resources for patients and their families dealing with RTA-Deafness.

Inheritance

Renal tubular acidosis with deafness (RTA-Deafness) is a rare genetic condition that affects the kidneys and the auditory system. It is inherited in an autosomal recessive manner, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.

The main gene associated with RTA-Deafness is the ATP6V1B1 gene. Mutations in this gene lead to a dysfunction in the transport of protons, resulting in impaired acid secretion in the renal tubules. This disruption in acid regulation causes metabolic acidosis, a condition in which the body accumulates too much acid.

Deafness is often present in individuals with RTA-Deafness, and it typically begins in childhood. The exact mechanism by which the ATP6V1B1 gene mutation leads to deafness is not fully understood, but it is thought to involve the loss of acidification in the inner ear, which affects the function of the nerve cells responsible for hearing.

Genetic testing can be used to confirm the diagnosis of RTA-Deafness. Testing for mutations in the ATP6V1B1 gene can be performed, and if a mutation is detected, it can provide evidence for the genetic cause of the condition. In some cases, additional genes may also be involved in the development of RTA-Deafness, and further genetic testing may be necessary to identify these novel causes.

For patients and families affected by RTA-Deafness, genetic counseling and support from advocacy groups and centers specializing in rare diseases can be beneficial. These resources can provide information and support about the condition, as well as connect individuals with relevant clinical trials or research studies.

References:

• “Renal tubular acidosis, distal, with progressive nerve deafness” – OMIM
• “Renal tubular acidosis with progressive nerve deafness” – Genetic and Rare Diseases Information Center
• “Inherited distal renal tubular acidosis associated with mutations in the H(+)-ATPase genes ATP6V0A4 and ATP6V1B1” – PubMed
• “Novel mutations in ATP6V1B1 and ATP6V0A4 causing distal renal tubular acidosis with and without deafness” – PubMed

Other Names for This Condition

• Distal renal tubular acidosis with sensorineural deafness
• Deafness with renal tubular acidosis
• Sensorineural deafness with distal renal tubular acidosis
• Deafness and renal tubular acidosis
• RRA1
• RRA2
• RRA3

Renal tubular acidosis with deafness (RTA with deafness) is also known by several other names. These alternative names provide additional information about this rare condition. RTA with deafness is a genetic disorder that affects the body’s ability to remove acid from the blood into the urine. The condition typically begins in early childhood and is associated with signs of renal tubular acidosis (RTA) and sensorineural deafness.

There are several subtypes of RTA with deafness, which are caused by mutations in different genes. The most common subtype is known as ATP6V1B1-related distal renal tubular acidosis with deafness (ATP6V1B1-related dRTA with deafness), which is inherited in an autosomal recessive manner.

For more information about this condition, you can visit the OMIM (Online Mendelian Inheritance in Man) catalog, which provides comprehensive information about genetic diseases. You can also find scientific articles about RTA with deafness on PubMed, a database of scientific publications. Clinical testing and genetic counseling services are available for individuals who have symptoms or a family history of RTA with deafness.

In addition, there are advocacy and support resources available for individuals and families affected by RTA with deafness. These resources can provide information, additional support, and help with navigating the medical system. Learning more about this condition can help patients and their families better understand the causes, symptoms, and treatment options for RTA with deafness.

References:

1. Besouw, M. T., Chambers, R. C., & Soleimani, M. (2015). From Clinical to Molecular Understanding of Renal Tubular Acidosis. Clinical Journal of the American Society of Nephrology, 10(8), 1541–1553.
2. Preminger, G. M., & Sakhaee, K. (2018). Principles of Renal Physiology, Acid-Base Disorders, & Renal Tubular Acidosis. In Campbell-Walsh-Wein Urology (12th ed., Vol. 4, pp. 4035–4049). Elsevier Saunders.
3. Peters, H. L., & Adrogue, H. J. (2019). Renal Tubular Acidosis. In T. E. Andreoli, C. J. Carpenter, C. J. Griggs, J. Loscalzo, & J. O. Kasper (Eds.), Cecil Essentials of Medicine (10th ed., pp. 327–328). Elsevier Saunders.

Additional Information Resources

Here is a list of additional resources that provide more information about renal tubular acidosis with deafness (RTA-D):

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – NIDDK provides comprehensive information about renal tubular acidosis, including the different types, signs and symptoms, diagnosis, and treatment options. Visit their website to learn more.

• PubMed – A database of scientific articles and research papers that provide in-depth clinical information about RTA-D. Search for the keywords “renal tubular acidosis with deafness” to find relevant articles and studies.

• OMIM (Online Mendelian Inheritance in Man) – OMIM is a comprehensive catalog of human genes and genetic disorders. They have a dedicated page on RTA-D that contains information about the gene (ATP6V1B1) and its associated condition, as well as inheritance patterns and gene frequency. Visit the OMIM website for more details.

• Nephrology Center of Excellence – A leading center for nephrology research and patient care. Their website provides information about various kidney diseases, including renal tubular acidosis. Visit their website to learn more about the condition and find resources for patients and healthcare professionals.

• Genetic and Rare Diseases Information Center (GARD) – GARD is a program of the National Center for Advancing Translational Sciences (NCATS) that provides reliable information about rare diseases. They have a dedicated page on RTA-D, with information about signs and symptoms, causes, and available genetic testing options. Visit the GARD website for more details.

These resources offer a wealth of information about renal tubular acidosis with deafness and can help patients, healthcare professionals, and researchers learn more about this rare metabolic condition.

Genetic Testing Information

Genetic testing plays a crucial role in the diagnosis and understanding of renal tubular acidosis with deafness (RTA-Deafness). This rare condition is caused by mutations in the ATP6V1B1 gene, also known as distal renal tubular acidosis (dRTA) with deafness. The ATP6V1B1 gene is responsible for encoding a subunit of the ATPase proton pump, which helps remove excess protons from the body.

Genetic testing for RTA-Deafness involves analyzing the ATP6V1B1 gene for mutations. This testing can be done through specialized genetic testing centers or laboratories that focus on genetic diseases. By identifying mutations in this gene, clinicians can confirm the diagnosis of RTA-Deafness and provide patients with more information about their condition.

In addition to the ATP6V1B1 gene, there may be other genes associated with RTA-Deafness that are yet to be discovered. Further scientific research is ongoing to uncover novel genes and genetic variants related to this condition.

Patients with RTA-Deafness typically present with signs of renal tubular acidosis, such as impaired kidney function and metabolic acidosis. The presence of deafness further distinguishes this condition from other causes of renal tubular acidosis.

Genetic testing for RTA-Deafness follows an autosomal recessive inheritance pattern. This means that individuals must inherit two copies of the mutated gene (one from each parent) to develop the condition. Carriers, who have one copy of the mutated gene, typically do not show signs or symptoms of the disease.

For clinicians and patients seeking additional information on genetic testing, there are several resources available. The Online Mendelian Inheritance in Man (OMIM) database provides comprehensive information on the ATP6V1B1 gene and its association with RTA-Deafness. Scientific articles, references, and clinical case reports are also valuable sources of information.

Patient support and advocacy groups are available to provide guidance and resources for individuals and families affected by RTA-Deafness. These organizations can offer access to genetic counseling, patient forums, and educational materials to help individuals better understand their condition.

Genetic testing plays a critical role in identifying and better understanding rare diseases such as RTA-Deafness. By uncovering genetic mutations, clinicians can provide patients with more accurate diagnoses, prognosis, and personalized treatment options.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is a program of the National Center for Advancing Translational Sciences (NCATS) and is dedicated to providing reliable information on genetic and rare diseases to patients, their families, and healthcare professionals.

GARD offers a comprehensive catalog of information on various genetic and rare diseases, including renal tubular acidosis with deafness. This autosomal recessive condition is characterized by the impaired ability of the kidneys to remove acids from the body and the associated hearing loss.

The GARD website provides the latest scientific and clinical information on renal tubular acidosis with deafness. Patients, their families, and healthcare professionals can learn about the signs and symptoms, causes, diagnosis, and management of this rare metabolic disorder.

Within the GARD website, you can find additional genetic resources such as the Online Mendelian Inheritance in Man (OMIM) database, which provides more information on the gene associated with renal tubular acidosis with deafness (ATP6V1B1). Other resources include PubMed references, advocacy groups, support organizations, and articles on this condition.

Renal tubular acidosis with deafness is a rare condition, and the frequency of its occurrence is currently unknown. However, research and evidence suggest that mutations in the ATP6V1B1 gene are the main cause of this condition.

Patients with renal tubular acidosis with deafness typically have distal renal tubular acidosis (dRTA) and nerve deafness. The condition usually begins in infancy or early childhood.

If you suspect that you or your child may have renal tubular acidosis with deafness, it is recommended to consult with a healthcare professional experienced in metabolic diseases. Genetic testing may be available to confirm the diagnosis.

In summary, the Genetic and Rare Diseases Information Center (GARD) is a valuable resource for individuals seeking information on genetic and rare diseases. For renal tubular acidosis with deafness, GARD provides scientific and clinical information, genetic resources, and additional support for patients and their families.

Patient Support and Advocacy Resources

This section provides information on support and advocacy resources for individuals affected by renal tubular acidosis with deafness (RTA with deafness) and their families.

Support and advocacy organizations play a crucial role in providing assistance, information, and resources for individuals affected by this condition. They typically work to remove barriers and improve the quality of life for patients and their families.

For individuals with RTA with deafness, there are several resources available. These resources provide information about the condition, its causes, and available treatments. They also offer support and guidance to help individuals navigate the challenges associated with this rare condition.

Patient Support Organizations

• National Center for Advancing Translational Sciences (NCATS) – The NCATS provides information and resources on rare diseases, including RTA with deafness. Their website offers a comprehensive database on rare diseases and includes information on symptoms, testing, diagnosis, and treatment options.
• Genetic and Rare Diseases Information Center (GARD) – GARD is a program of the National Center for Advancing Translational Sciences. They provide information on genetic and rare diseases, including RTA with deafness. Their website offers a variety of resources, including disease descriptions, frequency information, scientific articles, and references.
• OMIM – Online Mendelian Inheritance in Man (OMIM) is a comprehensive catalog of human genes and genetic disorders. OMIM provides information on the genes associated with RTA with deafness, such as ATP6V1B1. Their database includes detailed information about the genes, their functions, and the inheritance patterns associated with the condition.

Advocacy Organizations

• Rare Diseases UK – Rare Diseases UK is a national alliance for people with rare diseases and all who support them. They provide a platform for rare disease organizations and individuals to come together to campaign for better services, treatment, and support for those affected by rare diseases, including RTA with deafness.
• Deafness Research UK – Deafness Research UK is a UK-based charity dedicated to finding treatments and cures for deafness and hearing loss. They fund research projects and offer support and information to individuals with deafness and their families.
• National Institute on Deafness and Other Communication Disorders (NIDCD) – The NIDCD is a part of the National Institutes of Health (NIH). They support and conduct research on communication disorders, including deafness, and provide information to the public and healthcare professionals. Their website offers resources and information on various types of deafness and related conditions.

These organizations and resources can provide valuable support, information, and resources for individuals with renal tubular acidosis with deafness and their families. They can help individuals better understand the condition, find appropriate healthcare providers, and connect with others who are going through similar experiences.

It is important to note that the inclusion of these resources does not constitute an endorsement or recommendation. It is always recommended to consult with medical professionals and trusted healthcare providers for personalized advice and guidance.

Catalog of Genes and Diseases from OMIM

The Catalog of Genes and Diseases from OMIM provides a comprehensive list of genes and associated diseases. OMIM, the Online Mendelian Inheritance in Man, is a database that catalogs human genes and genetic disorders, including renal tubular acidosis with deafness.

Renal tubular acidosis with deafness, also known as distal renal tubular acidosis (dRTA), is a rare genetic condition characterized by impaired ability of the kidneys to acidify urine. This condition is often associated with deafness due to dysfunction of the inner ear nerve cells.

OMIM provides a list of genes associated with renal tubular acidosis with deafness. One of the known genes is ATP6V1B1, which encodes a protein involved in the control of protons and acids in the body. Mutations in this gene can result in dRTA with deafness.

In addition to genes, OMIM provides information on the clinical signs and symptoms, inheritance patterns, and other associated diseases of renal tubular acidosis with deafness. This information can support healthcare professionals in diagnosing and treating patients with this condition.

The frequency of renal tubular acidosis with deafness is relatively rare, and the condition can have a significant impact on patients’ quality of life. Therefore, it is essential to have access to scientific resources like OMIM to learn more about the condition.

OMIM also provides references to scientific articles and PubMed resources for further reading and research on renal tubular acidosis with deafness. This can help researchers and clinicians stay up-to-date with the latest evidence and advancements in the field.

In conclusion, the Catalog of Genes and Diseases from OMIM is a valuable resource for understanding the genetic and metabolic causes of renal tubular acidosis with deafness. It provides information on associated genes, clinical features, inheritance patterns, testing resources, and more. This catalog plays an important role in supporting the scientific and advocacy communities in their efforts to research, diagnose, and treat rare genetic diseases like renal tubular acidosis with deafness.

Scientific Articles on PubMed

Renal tubular acidosis with deafness (RTA-D) is a rare genetic condition that affects the body’s ability to remove acids. This condition is also known as distal renal tubular acidosis (dRTA). RTA-D is typically associated with deafness, as the condition often begins with symptoms affecting the nerve cells in the inner ear.

The ATP6V1B1 gene has been identified as the gene responsible for this condition. Mutations in this gene can cause a dysfunction in the transport of protons, which are necessary for the proper balance of acids in the body. This results in the accumulation of acid in the blood, leading to metabolic disturbances.

Scientific articles on PubMed provide clinical evidence, information, and more resources on this condition. These articles can support healthcare professionals in the diagnosis, testing, and management of patients with RTA-D. PubMed is a comprehensive database of scientific articles from various sources, making it an excellent resource for learning about rare diseases like RTA-D.

OMIM, the Online Mendelian Inheritance in Man catalog, is another valuable resource for genetic information. It provides detailed information on the inheritance and genetic basis of diseases, including RTA-D. OMIM can help researchers, physicians, and advocacy groups access additional information on this rare condition.

The causes and symptoms of RTA-D can vary from patient to patient, and the condition may present with different degrees of severity. Genetic testing can help identify mutations in the ATP6V1B1 gene and confirm the diagnosis of RTA-D in a patient.

Further research is needed to better understand the underlying mechanisms of RTA-D and develop effective treatments. By studying the genetic and metabolic aspects of this condition, scientists can gain more insight into the pathophysiology of RTA-D and potentially identify novel therapeutic targets.

In conclusion, scientific articles on PubMed provide valuable evidence, clinical information, and resources for understanding and managing RTA-D. The ATP6V1B1 gene has been identified as the genetic cause of this condition, and further research is necessary to unravel the complexities of RTA-D. Access to scientific literature, databases like OMIM, and genetic testing are crucial in advancing our understanding of this rare disease and improving patient outcomes.

References

• Renal Tubular Acidosis With Deafness

  National Center for Advancing Translational Sciences, Genetic and Rare Diseases Information Center. March 24, 2015.

  [source]

• RARE Diseases (OMIM)

  Online Mendelian Inheritance in Man (OMIM). Entry Number: 267300.

  [source]

• Renal Tubular Acidosis with Deafness (ATP6V1B1)

  Genetic Testing Registry. Bethesda (MD): National Center for Biotechnology Information (US); 2012 Sept 26.

  [source]

• Deafness, Autosomal Dominant 11

  Genetic Testing Registry. Bethesda (MD): National Center for Biotechnology Information (US); 2012 Sept 26.

  [source]

• Additional articles about Renal Tubular Acidosis with Deafness (PubMed)

  PubMed is a resource provided by the U.S. National Library of Medicine.

  [source]

• Renal Tubular Acidosis (RTA) Resources

  NephCure Kidney International is the only organization committed exclusively to support research seeking the cause of the two potentially debilitating kidney disease, Nephrotic Syndrome and Focal Segmental Glomerulosclerosis (FSGS).

  [source]

• Renal Tubular Acidosis with Deafness (ATP6V1B1)

  Genetic and Rare Diseases Information Center. ATP6V1B1-Related Distal Renal Tubular Acidosis.

  [source]